TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18287373

Group type: EXPERIMENTAL
Intervention: Breast-feeding initiated within 1 hour after birth
Number of subjects: 22838

Group type: EXPERIMENTAL
Intervention: Breast-feeding initiated within 24 hours after birth
Number of subjects: 22838

Group type: EXPERIMENTAL
Intervention: Partially breast-fed infants
Number of subjects: 22838

Group type: EXPERIMENTAL
Intervention: Late breast-feeding initiation (> 24 hours)
Number of subjects: 22838

Group type: EXPERIMENTAL
Intervention: Universal initiation of breast-feeding within the first day
Number of subjects: 22838

Group type: EXPERIMENTAL
Intervention: Universal initiation of breast-feeding within the first hour
Number of subjects: 22838
Study: 16005706

Group type: EXPERIMENTAL
Intervention: Verbal and non-verbal positive social reinforcement
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 36
Study: 12446059

Group type: EXPERIMENTAL
Intervention: Baseline white blood cell (WBC) count
Number of subjects: 2208

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) and elevated WBC
Number of subjects: 2208

Group type: EXPERIMENTAL
Intervention: High C-reactive protein (CRP)
Number of subjects: 2208
Study: 10473840

Group type: EXPERIMENTAL
Intervention: Balloon technique for measuring exhaled NO
Number of subjects: 16

Group type: COMPARATOR
Intervention: On-line measurement of exhaled NO
Number of subjects: 16
Study: 8934684

Group type: EXPERIMENTAL
Intervention: Difference limen (DL) for discriminating differences in onset time
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Context coding of stimulus information
Number of subjects: 0
Study: 1745618

Group type: EXPERIMENTAL
Intervention: Delayed graft function (group 1)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Immediate graft function (group 2)
Number of subjects: 18
Study: 6349535

Group type: EXPERIMENTAL
Intervention: Nocardia rubra cell wall skeleton (N-CWS)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Nocardia rubra cell wall skeleton (N-CWS) and adriamycin
Number of subjects: 226

Group type: COMPARATOR
Intervention: Adriamycin
Number of subjects: 226
Study: 31034260

Group type: EXPERIMENTAL
Intervention: High-Intensity Training (HIT)
Number of subjects: 25
Study: 29762709

Group type: EXPERIMENTAL
Intervention: KSHV shedding in mothers
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: KSHV shedding in children
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: EBV shedding in mothers
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: EBV shedding in children
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: KSHV shedding by sex in children
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: KSHV and EBV shedding relationship in mothers
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: EBV shedding in children based on KSHV shedding
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Relationship between anti-KSHV antibodies and KSHV shedding
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Relationship between antimalarial antibodies and KSHV shedding
Number of subjects: 500
Study: 29328637

Group type: EXPERIMENTAL
Intervention: Cream containing olive oil squalene
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: All active samples (including Alpine Rose stem cells)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Squalene-containing cream
Number of subjects: 76
Study: 24661518

Group type: EXPERIMENTAL
Intervention: Head-up tilt test (HUTT) at 60°, 70°, or 80°
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Positive response to HUTT (n=76)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Negative response to HUTT (n=31)
Number of subjects: 107
Study: 21835514

Group type: COMPARATOR
Intervention: 100% casein (A)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: hydrolysed whey (B)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: amino acids (C)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 40% casein/60% whey (D)
Number of subjects: 15
Study: 19228241

Group type: EXPERIMENTAL
Intervention: Task-oriented training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Task-oriented rehabilitation
Number of subjects: 0
Study: 18525490

Group type: EXPERIMENTAL
Intervention: MRI grading system for cervical intervertebral disc degeneration
Number of subjects: 300
Study: 15920716

Group type: EXPERIMENTAL
Intervention: Staff training program (full day seminar + one-hour guidance per month for six months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no staff training)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Staff training program
Number of subjects: 0
Study: 11958495

Group type: EXPERIMENTAL
Intervention: Patient decision aid based on multicriteria decision‐making theory
Number of subjects: 96

Group type: COMPARATOR
Intervention: Simple educational intervention
Number of subjects: 96
Study: 10426236

Group type: EXPERIMENTAL
Intervention: Customised fundal height charts
Number of subjects: 1272
Study: 7560143

Group type: EXPERIMENTAL
Intervention: Cognitive pretraining (written introduction to the group experience)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (written information on the history of group psychotherapy)
Number of subjects: 0
Study: 2268456

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-reported compliance
Number of subjects: 0
Study: 7367500

Group type: EXPERIMENTAL
Intervention: Prosthetic speech appliance
Number of subjects: 39

Group type: COMPARATOR
Intervention: Pharyngeal flap surgery
Number of subjects: 39
Study: 31377226

Group type: EXPERIMENTAL
Intervention: AQP5 levels in urine (measured in ng/mL)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: AQP5 levels in the highest tertile (16.0 ng/mL)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: AQP5 levels
Number of subjects: 700
Study: 30390409

Group type: EXPERIMENTAL
Intervention: CCB + fluvastatin (group B)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Valsartan (group C)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Valsartan + fluvastatin (group D)
Number of subjects: 189

Group type: COMPARATOR
Intervention: CCBs (group A)
Number of subjects: 189
Study: 25077918

Group type: EXPERIMENTAL
Intervention: Acute administration of 8 mg salbutamol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Two-week administration of 8 mg salbutamol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 25193873

Group type: EXPERIMENTAL
Intervention: β-blocker therapy
Number of subjects: 18254

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18254
Study: 22906006

Group type: EXPERIMENTAL
Intervention: VXM01 (oral DNA vaccine)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 19967671

Group type: EXPERIMENTAL
Intervention: Burst mode
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Pulse mode
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Linear mode
Number of subjects: 86
Study: 17606778

Group type: EXPERIMENTAL
Intervention: Vitamin C 200 mg daily for fifty days
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Vitamin C 500 mg daily for fifty days
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Vitamin C 1500 mg daily for fifty days
Number of subjects: 416

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study: 15668310

Group type: EXPERIMENTAL
Intervention: Discharge care plan intervention as per the Australian Enhanced Primary Care Package
Number of subjects: 189

Group type: COMPARATOR
Intervention: Existing hospital discharge processes (Control)
Number of subjects: 189
Study: 12584670

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 285

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 285
Study: 10341162

Group type: EXPERIMENTAL
Intervention: D-tagatose (75 g daily for 8 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: D-tagatose (75 g single dose)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sucrose (25 g with each meal for 8 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: No sugar supplements (for Type 2 diabetics for 8 weeks)
Number of subjects: 16
Study: 7489228

Group type: COMPARATOR
Intervention: Current smokers
Number of subjects: 874

Group type: COMPARATOR
Intervention: Women consuming fewer than 12 alcoholic drinks in the past 12 months
Number of subjects: 874

Group type: COMPARATOR
Intervention: Women who never used HRT
Number of subjects: 874

Group type: COMPARATOR
Intervention: Leisure time physical activity (LTPA) categories
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 874
Study: 2022861

Group type: EXPERIMENTAL
Intervention: Polyantibiotic cream applied three times daily from the first day of catheterization until bacteriuria was found.
Number of subjects: 747

Group type: COMPARATOR
Intervention: Routine meatal care with cleansing of the meatal surface during daily bathing (Control).
Number of subjects: 747
Study: 7078021

Group type: EXPERIMENTAL
Intervention: 1.0 mg of norethindrone acetate and 50 microgram ethinyl estradiol daily for 21 days with 7 days of placebo treatment in each cycle
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: One fifth of the hormone dose in form of a continuous daily medication
Number of subjects: 20

Group type: COMPARATOR
Intervention: Previous use of oral contraceptives
Number of subjects: 20

Group type: COMPARATOR
Intervention: No previous hormonal contraceptives
Number of subjects: 20
Study: 29680218

Group type: EXPERIMENTAL
Intervention: Hybrid Coronary Revascularization (HCR)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional Coronary Artery Bypass Grafting (CABG)
Number of subjects: 200
Study: 27233466

Group type: EXPERIMENTAL
Intervention: Suicidal ideation
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Loss of interest
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Anxiety
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Psychomotor agitation
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: High-risk behavior
Number of subjects: 530
Study: 24635039

Group type: EXPERIMENTAL
Intervention: Acceptance-enhanced orientation letter
Number of subjects: 0

Group type: COMPARATOR
Intervention: Orientation letter
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 24331802

Group type: EXPERIMENTAL
Intervention: NPPV
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control
Number of subjects: 135
Study: 20499825

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 9031

Group type: EXPERIMENTAL
Intervention: Nateglinide
Number of subjects: 9031

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9031
Study: 18422480

Group type: EXPERIMENTAL
Intervention: Prescription omega-3 fatty acid concentrates (P-OM3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: P-OM3
Number of subjects: 0
Study: 16638830

Group type: EXPERIMENTAL
Intervention: Lipido-colloid dressing
Number of subjects: 28

Group type: COMPARATOR
Intervention: Daily gauze dressing
Number of subjects: 28
Study: 14514397

Group type: EXPERIMENTAL
Intervention: F group supplemented orally with enteral nutrient Fresubin 750MCT containing medium (MCT) and long‐chain triglyceride (LCT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: N group with Nutrition containing only LCT
Number of subjects: 30
Study: 10975022

Group type: EXPERIMENTAL
Intervention: Lidamidine HCL (4 mg) taken orally t.i.d. with food
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 8973430

Group type: EXPERIMENTAL
Intervention: DTP-a mixed with Hib conjugate and i.p.v.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Separate injections of DTP-a, Hib conjugate, and i.p.v.
Number of subjects: 120
Study: 1405620

Group type: EXPERIMENTAL
Intervention: IVH
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Cholesterol gallstone group
Number of subjects: 33
Study: 6146112

Group type: EXPERIMENTAL
Intervention: Temazepam (30 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Camazepam (30 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31357037

Group type: EXPERIMENTAL
Intervention: Imagery rescripting (ImRs) sessions (1-6 sessions until a 35% reduction in symptoms was achieved)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Imagery rescripting (ImRs) sessions
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Baseline Y-BOCS
Number of subjects: 13
Study: 29572795

Group type: EXPERIMENTAL
Intervention: Paclitaxel and carboplatinum (first-line therapy)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Cisplatinum-based therapy (including doxorubicin and cyclophosphamide)
Number of subjects: 104
Study: 26374836

Group type: EXPERIMENTAL
Intervention: Dressing group (n = 54): povidone-iodine cleaning, mupirocin application, covered with sterile gauze
Number of subjects: 108

Group type: COMPARATOR
Intervention: Non-dressing group (n = 54): mupirocin application, uncovered exit site
Number of subjects: 108
Study: 24519843

Group type: EXPERIMENTAL
Intervention: Informed Decision-Making (IDM) questionnaire
Number of subjects: 99

Group type: COMPARATOR
Intervention: Doctor's explanation of underlying conditions leading to kidney failure
Number of subjects: 99

Group type: COMPARATOR
Intervention: Impact of dialysis on daily life
Number of subjects: 99

Group type: COMPARATOR
Intervention: Life-long need for dialysis
Number of subjects: 99

Group type: COMPARATOR
Intervention: Doctor's effort to ensure patient understanding
Number of subjects: 99

Group type: COMPARATOR
Intervention: Decision-making process
Number of subjects: 99
Study: 22106842

Group type: EXPERIMENTAL
Intervention: Expressive Writing Intervention (EWI)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Neutral writing control group
Number of subjects: 82
Study: 20814785

Group type: COMPARATOR
Intervention: Propofol (200 mcg/kg/min)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Propofol (120 mcg/kg/min) plus remifentanil (0.3 mcg/kg/min)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both protocols
Number of subjects: 15
Study: 17507744

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (0.3 g/kg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 16247118

Group type: EXPERIMENTAL
Intervention: Brace only
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Physical therapy only
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Combination of both (brace and physical therapy)
Number of subjects: 57
Study: 12073163

Group type: EXPERIMENTAL
Intervention: 200 mg L-5-hydroxytryptophan
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 10097221

Group type: EXPERIMENTAL
Intervention: Primary stenting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anticoagulation after stenting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bailout stenting for failed PTCA
Number of subjects: 0
Study: 7749496

Group type: EXPERIMENTAL
Intervention: CV 205‐502 (0.15 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Octreotide (0.1 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CV 205‐502 (0.3 mg/day) - chronic test
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CV 205‐502 (0.6 mg/day) and octreotide (0.6 mg/day) - combined therapy for 3 months
Number of subjects: 12
Study: 1645684

Group type: EXPERIMENTAL
Intervention: Intravenous famotidine (20 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Physiological saline (Control)
Number of subjects: 13

Group type: COMPARATOR
Intervention: 7% sodium bicarbonate (Control)
Number of subjects: 13
Study: 264922

Group type: EXPERIMENTAL
Intervention: alexidine mouthwash (0.035%)
Number of subjects: 207

Group type: COMPARATOR
Intervention: placebo solution
Number of subjects: 207
Study: 31168645

Group type: EXPERIMENTAL
Intervention: Caudal epidural steroid injections (ESIs)
Number of subjects: 68
Study: 29190751

Group type: EXPERIMENTAL
Intervention: Beetroot-based gel (BG) 100 g containing 12 mmol nitrate
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nitrate-depleted gel (PLA) 100 g
Number of subjects: 12
Study: 24874347

Group type: EXPERIMENTAL
Intervention: DBT group skills training
Number of subjects: 33

Group type: COMPARATOR
Intervention: Skills handouts
Number of subjects: 33
Study: 23286331

Group type: EXPERIMENTAL
Intervention: Nurse-led computer-supported telephone triage
Number of subjects: 3751

Group type: EXPERIMENTAL
Intervention: GP-led telephone triage
Number of subjects: 3751

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3751
Study: 16717300

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (150 mg/kg mixed in 250 mL of 5% dextrose infused in 20 min, followed by an infusion of 150 mg/kg in 250 mL of 5% dextrose over 24 h)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 70
Study: 15284686

Group type: EXPERIMENTAL
Intervention: Splenic aspiration
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bone marrow aspiration
Number of subjects: 50
Study: 10625727

Group type: EXPERIMENTAL
Intervention: Medically treated patients with collaterals
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Surgically treated patients with collaterals
Number of subjects: 681
Study: 8957921

Group type: EXPERIMENTAL
Intervention: Resin-modified glass-ionomer
Number of subjects: 17

Group type: COMPARATOR
Intervention: Resin composite
Number of subjects: 17
Study: 3994010

Group type: EXPERIMENTAL
Intervention: Thiopental, nitrous oxide and oxygen, enflurane, plus muscle relaxant
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Thiopental, nitrous oxide and oxygen, narcotic, plus muscle relaxant
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with tetracaine
Number of subjects: 30
Study: 29966458

Group type: EXPERIMENTAL
Intervention: DNR 36 mg/m2
Number of subjects: 307

Group type: COMPARATOR
Intervention: DOX 30 mg/m2
Number of subjects: 307
Study: 28701292

Group type: EXPERIMENTAL
Intervention: Tailored text message intervention (SMS group)
Number of subjects: 1139

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1139
Study: 25246512

Group type: EXPERIMENTAL
Intervention: L-Dopa
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salient loss outcomes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Null (neutral) reversal cues
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salient reversal cues
Number of subjects: 0
Study: 24410834

Group type: EXPERIMENTAL
Intervention: Statin therapy with pitavastatin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intensive lipid-lowering therapy with pitavastatin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Insulin use
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Serum levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Low serum DHA
Number of subjects: 50
Study: 22913431

Group type: EXPERIMENTAL
Intervention: Educational needs assessment tool and tailored educational interventions
Number of subjects: 5
Study: 19414572

Group type: EXPERIMENTAL
Intervention: 0.8 mg iclaprim/kg
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 1.6 mg iclaprim/kg
Number of subjects: 59

Group type: COMPARATOR
Intervention: 1 g vancomycin
Number of subjects: 59
Study: 17456225

Group type: EXPERIMENTAL
Intervention: Grass allergen tablet (GRAZAX)
Number of subjects: 17000000

Group type: COMPARATOR
Intervention: Symptomatic treatment (antihistamines and topical steroids)
Number of subjects: 17000000
Study: 15006124

Group type: EXPERIMENTAL
Intervention: Prescription by general practitioners for brisk exercise (30 minutes per day, 5 days per week)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Counselling by practice nurses based on psychological theory
Number of subjects: 151

Group type: COMPARATOR
Intervention: Use of the Health Education Authority booklet 'Getting active, feeling fit'
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Combination of prescription and counselling
Number of subjects: 151
Study: 11605558

Group type: EXPERIMENTAL
Intervention: Semantically similar encoding pairs (e.g., alluring-PRETTY)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semantically contrasting encoding pairs (e.g., drab-PRETTY)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semantically unrelated encoding pairs (e.g., sore-PRETTY)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semantically similar generation pairs (e.g., beautiful-PRETTY)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semantically contrasting generation pairs (e.g., ugly-PRETTY)
Number of subjects: 0
Study: 9520826

Group type: EXPERIMENTAL
Intervention: Demeclocycline (1200 mg daily, starting 5 days preoperatively to postoperative day 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8084686

Group type: EXPERIMENTAL
Intervention: Training in sports (field hockey and athletics) for 10 weeks, 45 minutes daily
Number of subjects: 288

Group type: COMPARATOR
Intervention: Control group (96 subjects)
Number of subjects: 288
Study: 2573138

Group type: EXPERIMENTAL
Intervention: Ionic contrast medium
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Non-ionic contrast medium
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (baseline measurements)
Number of subjects: 50
Study: 30451582

Group type: EXPERIMENTAL
Intervention: Laparoscopic gastric plication (LGP)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Mini gastric bypass (MGB)
Number of subjects: 91
Study: 28688677

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) applied with an InGaAlP diode (660nm‐100mW‐1J‐4J/cm2)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 94
Study: 25720702

Group type: COMPARATOR
Intervention: Traditional round block technique (Group A)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Modified round block technique with cardinal glandulo-glandular sutures (Group B)
Number of subjects: 44
Study: 23966556

Group type: EXPERIMENTAL
Intervention: DTaP(5)-IPV-Hib
Number of subjects: 0

Group type: COMPARATOR
Intervention: DTaP(3)-IPV/Hib
Number of subjects: 0
Study: 21516768

Group type: EXPERIMENTAL
Intervention: Cycloferon
Number of subjects: 0
Study: 18805054

Group type: EXPERIMENTAL
Intervention: Ropinirole
Number of subjects: 551

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 551